Pharma major plummets over 10% after third trial disappointment in a week
--------------------------------------------------------------------
Source: CNBC
Published: 2026-09-08 17:51 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
Novartis shares tanked 10% on Tuesday after the pharmaceutical giant said its del-desiran drug for muscle-wasting disorder failed in a late-stage trial.
--------------------------------------------------------------------